A domestic automobile giant has announced a maximum RMB 2 billion share repurchase plan; a lithium mining giant intends to sell H-shares at a discount and opportunistically divest its core overseas assets; the controlling shareholder of a national secret formula pharmaceutical company has secured a RMB 450 million loan specifically for share增持...
On February 4, Changan Automobile proposed to repurchase company shares with an amount ranging from 1 billion yuan to 2 billion yuan; Tianqi Lithium proposed to place 65 million new H-shares at a 9% discount; Pien Tze Huang's controlling shareholder obtained a special 'Loan Commitment Letter' for share增持.
The following are selected after-hours announcements:
Changan Automobile: Plans to Repurchase Company Shares with RMB 1 Billion to RMB 2 Billion
Changan Automobile announced that the company plans to repurchase its shares with an investment of RMB 1 billion to RMB 2 billion. The upper limit for the repurchase price will not exceed 150% of the average trading price of the company's stock over the 30 trading days prior to the board's resolution approving the repurchase plan.
Tianqi Lithium: Plans to Sell 65 Million New H Shares at a 9% Discount
Tianqi Lithium (09696.HK) announced on the Hong Kong Stock Exchange that the company and the placing agents entered into a placing agreement on February 3, 2026 (after trading hours). The number of shares to be placed represents approximately 39.64% of the existing issued H shares (i.e., 65,050,000 H shares) and approximately 3.96% of the total number of issued shares as of the date of this announcement. The placing price per share is HKD 45.05 (a discount of approximately 9%).
Pientzehuang: Controlling Shareholder Obtains Special 'Loan Commitment Letter' for Share Acquisition
Pientzehuang announced that recently, the Zhangzhou Branch of ICBC has issued a 'Loan Commitment Letter' to the controlling shareholder, Jiulongjiang Group, agreeing to provide special loan support for the acquisition of the company’s shares by Jiulongjiang Group. The loan amount does not exceed RMB 450 million, with a loan term of three years. Apart from the aforementioned loan, the remaining funds for this share acquisition by Jiulongjiang Group are from its own resources.
Fuchuang Precision: SDIC Venture Capital Fund plans to reduce its holdings by no more than 3%. Other major shareholders plan to reduce their holdings by no more than 17,945 shares.
Fuchuang Precision announced that SDIC (Shanghai) Technology Achievement Transformation Venture Capital Investment Fund Enterprise (Limited Partnership) intends to reduce its holdings through centralized bidding and block trading methods between March 6, 2026, and June 5, 2026. The total reduction will not exceed 9,186,300 shares, representing 3% of the company’s total share capital, including no more than 3,062,100 shares via centralized bidding and no more than 6,124,200 shares via block trading. Ni Shiwen, Song Yang, Song Yansong, and Chen Xiyao intend to respectively reduce their holdings via centralized bidding by no more than 6,633 shares, 2,948 shares, 3,445 shares, and 4,919 shares, with reduction percentages not exceeding 0.0022%, 0.0010%, 0.0011%, and 0.0016%, respectively.
Changhong Huayi: Directors and senior management plan to increase their shareholding by an amount of no less than 3,358,300 yuan.
Changhong Huayi announced that some directors and senior management members plan to increase their shareholdings through centralized bidding within 3.5 months from the date of this announcement. The total amount of the increase will be no less than 3,358,300 yuan, sourced from performance incentive funds and personal funds. The period for the increase will be from February 5, 2026, to May 19, 2026, without any price range restrictions. Shares purchased during this round of increases may not be sold within three years from the completion of the purchase.
Ruixin Technology: Proposed issuance of shares and cash payment for asset acquisition alongside配套 fundraising; stock trading suspension.
Ruixin Technology announced that the company is planning to acquire assets through the issuance of shares and cash payments while also raising配套 funds. This transaction is expected to constitute a significant restructuring as defined by the 'Measures for the Administration of Major Restructuring of Listed Companies.' Trading of the company’s securities has been suspended starting from the market opening on February 5, 2026, and the transaction details are expected to be disclosed within no more than 10 trading days. The target company in this transaction is Wuhu Deheng Auto Equipment Co., Ltd., with preliminary identified counterparties including Tong Xiaoping and Zhang Yapeng, who are actual controllers of the target company, along with certain other shareholders.
Shengxin Lithium Energy: Wholly-owned subsidiary Shengxin Lithium plans to acquire 13.93% equity in Huirong Mining for 1.26 billion yuan.
Shengxin Lithium Energy announced that its wholly-owned subsidiary, Shengxin Lithium, plans to acquire 13.93% equity in Yajiang Huirong Mining Co., Ltd. held by Xiamen Chuangyi Shengxin New Energy Industry Investment Partnership (Limited Partnership) for 1.26 billion yuan in cash. Upon completion of this transaction, the company will hold 100% of Huirong Mining.
Shanjin International: 1,834,900 shares have been repurchased at a total cost of RMB 34,092,500.
Shanjin International announced on February 4 that as of January 31, 2026, the company has cumulatively repurchased 1,834,929 shares through its dedicated securities account for stock repurchases via centralized bidding. These shares represent 0.07% of the company's total share capital. The highest transaction price was RMB 19.45 per share, and the lowest was RMB 17.85 per share. The total transaction amount was RMB 34,092,534.43 (excluding transaction fees). The funding source for this share repurchase includes the company’s own funds and a special loan for repurchases. The repurchase price did not exceed the predetermined ceiling of RMB 29.70 per share (inclusive). The progress of the company’s share repurchase is in line with the established repurchase plan and complies with relevant laws and regulations.
Debao Group: Controlling shareholder Zhongweizi Investment plans to reduce its holdings by no more than 2%.
The Debao Group announced that its controlling shareholder, Zhongweizi Investment Management Co., Ltd. of Shanghai, plans to reduce its holdings by up to 2.9028 million shares through block trades from March 6, 2026, to June 5, 2026, due to funding needs. This represents 1.9207% of the company’s total share capital of 151 million shares and 2.0000% of the adjusted total share capital (after deducting treasury shares) of 145 million shares. The shares in question were held prior to the initial public offering. Currently, Zhongweizi holds 47.6222 million shares, accounting for 31.5091% of the total share capital. The selling price will be determined based on market prices but will not fall below the issue price.
CETC Digital: Chairman and Legal Representative Jiang Bo and Director Yu Kaiyong Resign
CETC Digital announced that the board of directors recently received written resignation reports from the chairman and legal representative, Jiang Bo, as well as director Yu Kaiyong. Due to work-related changes, Jiang Bo has applied to step down from his positions as chairman of the 10th board of directors, director, chairperson of the Strategy and Investment Committee, and member of the Nomination Committee, while also ceasing to serve as the company's legal representative. Yu Kaiyong has similarly resigned from his roles as a director of the 10th board of directors and member of the Strategy and Investment Committee due to work-related changes. Following their resignations, both Jiang Bo and Yu Kaiyong will no longer hold any positions within the company.
Jinjing Technology: TCO glass sales revenue accounted for a relatively low proportion of total operating revenue from January to September 2025.
Jinjing Technology's stock trading abnormal fluctuation announcement noted that the company has observed market attention regarding the progress of its TCO glass market. As of now, the TCO glass industry remains relatively small. According to preliminary company statistics, TCO glass sales revenue from January to September 2025 accounted for a relatively low proportion of total operating revenue during the same period, and did not have a significant impact on current operating revenue.
Yuxing Shares: Director Liu Quan Plans to Reduce Holdings by 0.22%
Yuxing Shares announced that director Liu Quan holds 3.3594 million shares of the company, accounting for 0.89%. Due to financial needs, he plans to reduce his holdings by no more than 839,800 shares, or 0.22%, through centralized bidding between March 6, 2026, and June 3, 2026. The shares to be reduced were originally issued prior to the initial public offering, and the reduction price will be determined based on the secondary market price at the time of the transaction.
Guai Pet: Shareholders Beijing Junlian and Zhuhai Junlian Plan to Reduce Holdings by 1.32% and 0.58%, Respectively
Guai Pet announced that Beijing Junlian Shengyuan Equity Investment Partnership (Limited Partnership) and its acting-in-concert party, Zhuhai Junlian Boyuan Equity Investment Partnership (Limited Partnership), collectively hold 33.3421 million shares, representing 8.33% of the company’s total share capital. They plan to reduce their holdings by up to 7.61 million shares via centralized bidding or block trades from March 6, 2026, to June 5, 2026, which accounts for 1.90%. Specifically, Beijing Junlian intends to reduce its holdings by up to 5.288 million shares (1.32%), while Zhuhai Junlian plans to reduce by up to 2.322 million shares (0.58%). As of the announcement date, the company’s total share capital is 400 million shares.
Hongchang Technology: Proposed Acquisition of 21% Equity in Liangzhi Joint
Hongchang Technology announced that the company plans to acquire a total of 21% equity in Liangzhi Joint held by Rostecahsi Transmission Equipment (Zhejiang) Co., Ltd., Mr. Jianpin Zhou, and Mr. Tao Fang. After the acquisition is completed, Hongchang Technology will hold 51% of Liangzhi Joint's equity, becoming the controlling shareholder of Liangzhi Joint. This external investment matter has been reviewed and approved at the tenth meeting of the third board of directors of the company, and does not need to be submitted to the shareholders' meeting for review.
Shuangliang Energy-Saving: 'Space-based Photovoltaics' Remain in the Exploration and Ground Verification Phase with No Substantial Contribution to Current Performance
Shuangliang Energy-Saving issued an announcement regarding abnormal fluctuations in stock trading. Recently, there has been a significant increase in attention on concept sectors such as 'commercial spaceflight' and 'space-based photovoltaics' in the capital markets, with related stocks performing actively. Over the past two years, the company has not recognized any revenue related to commercial spaceflight projects, and future business development in this area remains uncertain. The company’s main products related to the photovoltaic industry include multi-crystalline silicon reduction furnace systems, monocrystalline silicon, and high-efficiency photovoltaic modules. However, 'space-based photovoltaics' remain in the technological exploration and ground verification stage. Their commercialization pathways, cost structures, in-orbit maintenance systems, and other factors still face major uncertainties and have not yet formed an industrial closed loop ready for large-scale implementation. Therefore, these developments have not made any substantial contribution to the company's current performance. The board hereby reminds investors to fully recognize the risks inherent in the stock market and avoid blindly chasing market trends. Investors are encouraged to enhance risk awareness and conduct investments prudently.
Jingsheng Machinery: The application scenario of 'Space Photovoltaics' is currently still in the exploratory stage.
Jingsheng Machinery issued an unusual trading announcement stating that the application scenario of 'Space Photovoltaics' is currently still in the exploratory stage, and the industrialization process still faces uncertainties. The company’s main business includes the research, production, and sales of equipment for the photovoltaic industry chain such as silicon wafers, batteries, and modules, as well as auxiliary materials and consumables like quartz crucibles and diamond wire. As market attention on the photovoltaic sector continues to increase, it may indirectly influence investors’ expectations regarding the company’s future business expansion. The company hereby reminds all investors to fully recognize the risks of the stock market, avoid blindly chasing market trends, make prudent decisions, and conduct rational investments to prevent investment risks caused by concept speculation.
Guangdong Construction Engineering: Consortium Wins 1.524 Billion Yuan Project
Guangdong Construction Engineering announced that a consortium consisting of its wholly-owned subsidiary Guangdong Fourth Construction and United Creation Design Co., Ltd. has been awarded the contract for the 'Annual Production of 2GWh Three-Dimensional Solid-State Lithium Battery Intelligent Manufacturing (Yugan, Jiangxi) Production Base Project.' The winning bid amount is 1.524 billion yuan. The project covers an area of 100 mu, with a planned total construction area of 167,000 square meters, including production workshops, research and development centers, warehouses, employee dormitories, training and operation maintenance centers, office buildings, and supporting facilities.
CSSC Fangdu: Signed construction contracts for 16 feeder container vessels with a total contract value between USD 736 million and USD 896 million.
CSSC Fangdu announced that its controlling subsidiary, CSSC Huangpu Wenchong Shipbuilding Co., Ltd., signed construction contracts for 16 feeder container vessels with EVERGREEN MARINE (ASIA) PTE. LTD. The total contract value is between USD 736 million and USD 896 million. The contract performance period will commence upon the contract's effectiveness until the delivery of the vessels, with planned delivery dates from 2028 to 2030 or earlier. The fulfillment of the contract is expected to have a positive impact on the company’s cash flow and subsequent operating performance.
Qingda Environmental Protection: Shareholder Binglun Environment plans to reduce holdings by no more than 3%.
Qingda Environmental Protection announced that shareholder Binglun Environment holds 9.3609 million shares, representing 7.54% of the total. Due to operational needs, it plans to reduce its holdings by up to 3.7268 million shares through centralized bidding and block trades from March 9, 2026, to June 8, 2026, representing a maximum proportion of 3%. Among this, centralized bidding will account for no more than 1.2423 million shares (1%), while block trades will be limited to 2.4845 million shares (2%). Previously, Binglun Environment reduced its holdings by 230,000 shares (0.2429%) between June 8, 2023, and June 9, 2023.
Tiantong Shares, with three limit-up days in four trading sessions: No Change in Core Business; Company Does Not Manufacture Commercial Satellites or Optical Modules
Tiantong Co., Ltd. issued a risk advisory announcement stating that its stock price surged to the daily limit over three trading days from January 30 to February 4, 2026, with a cumulative increase of 37.39% and a total turnover rate of 58.06%. These indicators are significantly higher than the industry's average levels during the same period, indicating potential substantial downside risks in subsequent trading. The company forecasts that its net profit attributable to parent company shareholders for the fiscal year 2025 will range between -RMB 120 million and -RMB 170 million. Additionally, its net profit attributable to parent company shareholders after deducting non-recurring gains and losses is expected to be between -RMB 170 million and -RMB 220 million. The company’s main business has not changed, and it does not produce commercial satellites or optical module products.
Shanghai Pharmaceuticals: Plans to Publicly List the Transfer of 30% Equity in Bristol-Myers Squibb China
Shanghai Pharmaceuticals announced its intention to transfer a 30% stake in Bristol-Myers Squibb China through a public listing on a property rights exchange, with a minimum listing price of no less than RMB 1.023 billion. This transaction does not constitute a related-party transaction nor a major asset restructuring. The transaction has been approved by the company’s twenty-eighth meeting of the eighth board of directors and does not need to be submitted to the shareholders' meeting. The transaction still requires the public listing process on the property rights exchange, and the transferee and final transaction price have yet to be determined.
Beixin Road & Bridge: Company Wins 1.145 Billion Yuan Project
Beixin Road & Bridge announced that it recently received the 'Notice of Award' from Anhui Jiangyi Guoguan Port Investment Development Co., Ltd. A consortium composed of Wuhan Yangtze River Waterway Engineering Bureau (as the lead party), the company's subsidiary Anhui Beixin Construction Engineering Co., Ltd., and Hebei Zhedian Construction Engineering Co., Ltd. has been confirmed as the winning bidder for Package One of the EPC General Contracting for the Wanjiang Bulk Cargo Sand and Stone Distribution (Road, Rail) Intermodal Center Wharf Project. Additionally, a consortium consisting of the company (as the lead party) and Wuhan Yangtze River Waterway Engineering Bureau has been determined as the winning bidder for Package Two of the project. The awarded amount for Package One is 223 million yuan, while the awarded amount for Package Two is 921 million yuan.
Conba: Subsidiary TFA003 tablets receive clinical trial approval notice
Conba announced that its wholly-owned subsidiary, Hangzhou Conba, has received the 'Clinical Trial Approval Notice' for TFA003 tablets issued by the National Medical Products Administration. The indication applied for TFA003 tablets is diabetic nephropathy, and the registration classification falls under Category 2.1 of traditional Chinese medicine (modifying the administration route of marketed traditional Chinese medicine) and Category 2.3 (expanding therapeutic indications). Results from pharmacodynamics and pharmacokinetics animal experiments conducted on this product indicate that TFA003 exhibits efficacy in treating diabetic nephropathy, significantly improving renal function indicators in urine and blood, enhancing glomerular filtration and renal tubular reabsorption functions, and improving kidney pathological morphology. This demonstrates the potential to develop it into a new traditional Chinese medicine for diabetic nephropathy. To date, Hangzhou Conba has invested approximately RMB 29.57 million in research and development costs for this product.
*ST Tian Shan: January 2026 Live Livestock Sales Revenue of RMB 7,200
*ST Tian Shan announced that in January 2026, the company sold five live livestock animals with revenue of RMB 7,200. The month-on-month changes were -99.74% and -99.97%, respectively, while the year-on-year changes were -98.91% and -99.83%. Based on comprehensive considerations such as breeding operation plans and cattle growth cycles, the company adjusted the timing of cattle sales accordingly. The reduction in the quantity and revenue of live livestock sales on a month-on-month and year-on-year basis this month was primarily due to the concentrated sales earlier to meet market demand, and this month's adjustment reflects a normal cyclical rhythm.
Jianmi Industry: Received Administrative Regulatory Measures Decision Letter from the Hunan Securities Regulatory Bureau, Ordered to Correct Due to Inflated Revenue
Jinjian Cereals Industry announced that the company and relevant responsible persons have received an administrative regulatory measure decision from the Hunan Securities Regulatory Bureau. Upon investigation, from 2020 to 2022, all 14 trade transactions between the company's former subsidiary, Jinjian Agricultural Products (Yingkou) Co., Ltd., and Orient Group Co., Ltd. and its related parties were found to be circular trades without physical delivery and lacking commercial substance; thus, revenue should not have been recognized. In 2020, four trade transactions conducted by Jinjian Yingkou with Nehe Grain Group Co., Ltd. of Heilongjiang Province and Liaoning Pengda Agricultural Development Co., Ltd. were actually customer-commissioned auctions for state temporary reserve grain or reserve grain businesses, with all associated risks borne by the customers. Revenue should not have been recognized using the gross method. The above two issues resulted in the company overstating operating revenue by RMB 228 million, RMB 266 million, and RMB 92.956 million for the years 2020, 2021, and 2022, respectively, accounting for 3.98%, 3.96%, and 1.45% of annual operating revenue, respectively; overstating operating costs by RMB 228 million, RMB 265 million, and RMB 92.8844 million, accounting for 3.99%, 3.95%, and 1.43% of annual operating costs, respectively; and overstating total profit by RMB 104,300, RMB 310,400, and RMB 71,600, representing 0.31%, -1.19%, and -0.16% of annual total profit, respectively.
China Galaxy: Approved to Publicly Issue Subordinated Bonds with a Total Face Value of No More Than 20 Billion Yuan to Professional Investors
China Galaxy announced that it recently received the 'Approval for the Registration of Public Issuance of Subordinated Bonds by China Galaxy Securities Co., Ltd. to Professional Investors' issued by the China Securities Regulatory Commission, approving the company to publicly issue subordinated bonds with a total face value of no more than 20 billion yuan to professional investors. This approval is valid for 24 months from the date of registration approval, and the company can issue subordinated bonds in tranches within the validity period of the registration.
Gestone: First-class innovative drug for hepatitis B treatment, Nerikewei GST-HG141, completes patient enrollment for Phase III clinical trial
Gestone announced that the Phase III clinical trial of its first-class innovative drug for hepatitis B treatment, Nerikewei GST-HG141, has recently completed the enrollment of all participants, with a total of 578 cases enrolled. GST-HG141 is being evaluated in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical trial for the combined treatment of patients with chronic hepatitis B (CHB) who have shown inadequate response to antiviral drugs. The primary objective is to assess the efficacy and safety of GST-HG141 treatment in CHB patients with poor response to prior antiviral drug therapy.
Shanhe Pharmaceutical Excipients: The company successfully passed the FDA on-site inspection in the United States.
Shanhe Pharmaceutical Excipients announced that the company underwent an on-site inspection by the U.S. Food and Drug Administration (FDA) from December 4, 2025, to December 5, 2025. The scope of the inspection covered six major systems: quality management, production management, facilities and equipment management, laboratory quality control, material and packaging labeling management. The company received the FDA’s Establishment Inspection Report (EIR), confirming that the inspection had been completed and that the company had successfully passed the FDA on-site inspection.
Chinese Online: Plans to collaborate with Tencent Computer on animation micro-short licensing cooperation
Chinese Online announced that the company and its subsidiaries plan to collaborate with Tencent Computer on licensing cooperation related to animated micro-shorts. Through uploading completed animated micro-shorts that meet the requirements of the agreement and individual contracts onto Tencent Video’s content creation service platform, the estimated cooperation value is RMB 23.2 million. These related-party transactions are business-related to the company’s daily operations, and the cooperation aligns with the company’s strategic development direction. The collaboration leverages each party's technological and market advantages, achieving complementary strengths and resource sharing, which will further enhance the company’s sustainable development capabilities and core competitiveness.
Yongzhen Co., Ltd.: Junlian Xiangdao and Junlian Jiamao completed a combined reduction of 3%.
Yongzhen Co., Ltd. announced that the reduction plans by Suzhou Junlian Xiangdao and Zhuhai Junlian Jiamao have been fully implemented. From December 9, 2025, to February 3, 2026, they collectively reduced their holdings by 7.1176 million shares, accounting for 3% of the company's total share capital. This included 2.3725 million shares through centralized bidding and 4.7451 million shares through block trading, with prices ranging from 17.87 to 23.35 yuan per share, resulting in a total transaction value of 136 million yuan. After the reduction, their combined shareholding is 15.1252 million shares, representing 6.38% of the total shares, down from 22.2428 million shares, or 9.38%, prior to the reduction.
Guosheng Technology: The company is currently not involved in space-based photovoltaic business.
Guosheng Technology issued an unusual trading activity announcement. The company's stock price recorded cumulative gains exceeding 20% over three consecutive trading days on February 2, 2026, February 3, 2026, and February 4, 2026. According to the relevant provisions of the Shanghai Stock Exchange Trading Rules, this constitutes abnormal stock trading fluctuations. Some self-media outlets reported that the company provides HJT photovoltaic systems to a commercial space company and is involved in space-based photovoltaic business. The company’s heterojunction (HJT) battery module products are mainly used in centralized power stations, distributed power stations, and similar scenarios. The company is currently not involved in space-based photovoltaic business. Investors are advised to exercise rational judgment.
Hainan Mining: Planning to Acquire Control of Luoyang Fengrui Fluorine Industry Co., Ltd., Shares to Remain Suspended
Hainan Mining announced that the company is planning to acquire control of Luoyang Fengrui Fluorine Industry Co., Ltd. through a combination of share issuance and cash payment, along with raising supporting funds. As of the date of this announcement, the company and relevant parties are actively advancing the related work for this transaction. All parties involved are currently in communication and negotiation regarding the transaction plan. Given that certain details still require thorough discussion, and to ensure fair disclosure of information while safeguarding investor interests, the company’s A-shares will continue to be suspended in accordance with the relevant regulations of the Shanghai Stock Exchange.
HBP: The company has signed a contract worth USD 225 million with NK Petroleum Company.
According to an announcement by HBP, the company has finalized a contract with NK Petroleum Company Limited for the resumption of production at the Naft Khana oilfield. The contract value amounts to USD 225 million (approximately RMB 1.596 billion). The performance period of the contract will involve achieving provisional acceptance of the EPC works within 18 months starting from December 1, 2025, followed by 36 months of operation and maintenance services. If this project contract is executed successfully, it is expected to have a positive impact on the company's operating performance for the fiscal years 2026-2027 and future years.
Guangyang Shares: Signs a cooperation agreement with Shenzhen Xuan Chuang and others to jointly develop, produce, and sell high-end specialized robotic products
Guangyang Shares announced that it has signed a 'Strategic Cooperation Agreement' with Shenzhen Xuan Chuang Robotics Co., Ltd. and Huangshan Guangyang Robotics Co., Ltd., aiming to conduct comprehensive strategic cooperation regarding Shenzhen Xuan Chuang's full range and models of specialized robotic products. Through deep integration and collaborative innovation, the three parties will jointly develop, produce, and sell high-end specialized robotic products, enhancing their core competitiveness and brand value within the industry chain. The signing of this strategic cooperation agreement does not require submission to the company’s board of directors or shareholders’ meeting for review and does not constitute a major asset restructuring as defined by the 'Measures for the Administration of Major Asset Restructuring of Listed Companies.'
DBN Group: Actual controller and chairman Shao Genhuo passed away due to illness on February 3.
DBN Group announced that the company's actual controller and chairman, Mr. Shao Genhuo, passed away at the age of 60 due to illness on February 3, 2026. The shares held by Mr. Shao Genhuo will be processed in accordance with relevant laws and regulations, and the company will promptly fulfill its information disclosure obligations. Following the passing of Mr. Shao Genhuo, the number of current directors has decreased from nine to eight, which will not result in the number of board members falling below the legally required minimum threshold.
Zhifei Biological Products: Freeze-dried Varicella Inactivated Vaccine Receives Clinical Trial Approval
Zhifei Biological Products announced that the company recently learned that the freeze-dried varicella inactivated vaccine developed by its wholly-owned subsidiary, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd., has received a clinical trial approval notice from the National Medical Products Administration, permitting the initiation of clinical trials to prevent varicella caused by varicella-zoster virus infection. As of the date of this announcement, according to information retrieved from the official website of the National Medical Products Administration, eight varicella live attenuated vaccines have been approved for marketing and use domestically, but no varicella inactivated vaccine has been officially approved for market yet, indicating broad market prospects.
Chengzhi Co., Ltd.: Successful Trial Production of Ultra-High Molecular Weight Polyethylene Project by Subsidiary
Chengzhi Co., Ltd. announced that at the second extraordinary meeting of the seventh board of directors held on August 30, 2022, the company reviewed and approved the proposal regarding the investment by its subsidiary Qingdao Huaqing in POE and ultra-high molecular weight polyethylene projects. The plan is to construct an ultra-high molecular weight polyethylene project through its wholly-owned subsidiary, Qingdao Chengzhi Huaqing Chemical New Materials Co., Ltd., located in the Dongjiakou Economic Zone of the West Coast New Area in Qingdao. Recently, the ultra-high molecular weight polyethylene facility successfully completed a one-time material feeding trial run, with stable operation and smooth production of products with uniform particle size and excellent quality.
China CITIC Bank: Plans to Increase Capital in CITIC Financial Leasing by RMB 2 Billion
According to an announcement by China CITIC Bank, at the 21st meeting of the seventh board of directors held on February 4, 2026, via an in-person meeting, a resolution was passed regarding the 'Capital Supplement Plan for CITIC Financial Leasing Co., Ltd.' The proposal received nine valid votes, with the voting results as follows: nine votes in favor, zero against, and zero abstentions. Based on the resolution of the board meeting, the board agreed that the bank would use its own funds to inject an additional RMB 2 billion into CITIC Financial Leasing in cash. After this capital increase is completed, the registered capital of CITIC Financial Leasing will increase from RMB 10 billion to RMB 12 billion, and the bank will continue to hold 100% of CITIC Financial Leasing's equity.
Chongqing Beer: Net profit of 1.231 billion yuan in 2025, a year-on-year increase of 10.43%.
Chongqing Beer announced that in the fiscal year 2025, the company achieved total operating revenue of 14.722 billion yuan, a year-on-year increase of 0.53%; net profit reached 1.231 billion yuan, a year-on-year increase of 10.43%.
Tianqi Lithium: Plans to sell over 62.55 million shares of SQM at an appropriate time.
Tianqi Lithium (09696.HK) announced on the Hong Kong Stock Exchange that the company intends to dispose of no more than 3,565,970 Class A shares of SQM at an appropriate time. The board has authorized the company's management to sell 62,556,568 Class A shares of SQM held by the company through its wholly-owned subsidiary Tianqi Zhili within one year based on securities market conditions. The management is also authorized to determine the specific sales plan (including but not limited to setting the sale price, quantity, and method, etc.). This authorization will be valid for one year from the date of approval by the board.
